Overview

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Status:
RECRUITING

Trial end date:
2028-11-19

Target enrollment:

Participant gender:

Summary

This study aims to assess the efficacy of methylprednisolone combined with concurrent chemoradiotherapy in treating unresectable or recurrent thymoma.

Phase:

PHASE2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Methylprednisolone
Radiotherapy